{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:03:39Z","timestamp":1795057419147,"version":"4.10.2"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"49","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,12,18]]},"DOI":"10.1038\/s41388-025-03624-5","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:36:37Z","timestamp":1763620597000},"page":"4814-4831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7865-7091","authenticated-orcid":false,"given":"Heidi","family":"Pharo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Marie","family":"Vedeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9553-7824","authenticated-orcid":false,"given":"Ingrid Vikan","family":"Sjurgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-9345","authenticated-orcid":false,"given":"Guro Elisabeth","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"3624_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","volume":"10","author":"E Crowley","year":"2013","unstructured":"Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10:472\u201384.","journal-title":"Nat Rev Clin Oncol"},{"key":"3624_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","volume":"19","author":"A Tivey","year":"2022","unstructured":"Tivey A, Church M, Rothwell D, Dive C, Cook N. Circulating tumour DNA\u2014looking beyond the blood. Nat Rev Clin Oncol. 2022;19:600\u201312.","journal-title":"Nat Rev Clin Oncol"},{"key":"3624_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","volume":"36","author":"JD Merker","year":"2018","unstructured":"Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, et al. Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review. JCO. 2018;36:1631\u201341.","journal-title":"JCO"},{"key":"3624_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01543-7","volume":"21","author":"SN Lone","year":"2022","unstructured":"Lone SN, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022;21:79.","journal-title":"Mol Cancer"},{"key":"3624_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.devcel.2010.10.005","volume":"19","author":"M Berdasco","year":"2010","unstructured":"Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell. 2010;19:698\u2013711.","journal-title":"Dev Cell"},{"key":"3624_CR6","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349:2042\u201354.","journal-title":"N Engl J Med"},{"key":"3624_CR7","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148\u201359.","journal-title":"N Engl J Med"},{"key":"3624_CR8","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002;21:5400\u201313.","journal-title":"Oncogene"},{"key":"3624_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.10","volume":"49","author":"M Kim","year":"2017","unstructured":"Kim M, Costello J. DNA methylation: an epigenetic mark of cellular memory. Exp Mol Med. 2017;49:e322.","journal-title":"Exp Mol Med"},{"key":"3624_CR10","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/j.clcc.2018.02.012","volume":"17","author":"M-B Worm \u00d8rntoft","year":"2018","unstructured":"Worm \u00d8rntoft M-B. Review of blood-based colorectal cancer screening: how far are circulating cell-Free DNA methylation markers from clinical implementation?. Clinical Colorectal Cancer. 2018;17:e415\u201333.","journal-title":"Clinical Colorectal Cancer"},{"key":"3624_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","volume":"20","author":"A Kustanovich","year":"2019","unstructured":"Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biol Ther. 2019;20:1057\u201367.","journal-title":"Cancer Biol Ther"},{"key":"3624_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14:985\u201390.","journal-title":"Nat Med"},{"key":"3624_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35959-6","volume":"14","author":"Y An","year":"2023","unstructured":"An Y, Zhao X, Zhang Z, Xia Z, Yang M, Ma L, et al. DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation. Nat Commun. 2023;14:287.","journal-title":"Nat Commun"},{"key":"3624_CR14","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1021\/ja910264z","volume":"132","author":"JS Choy","year":"2010","unstructured":"Choy JS, Wei S, Lee JY, Tan S, Chu S, Lee T-H. DNA methylation increases nucleosome compaction and rigidity. J Am Chem Soc. 2010;132:1782\u20133.","journal-title":"J Am Chem Soc"},{"key":"3624_CR15","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1093\/nar\/gks893","volume":"41","author":"CK Collings","year":"2013","unstructured":"Collings CK, Waddell PJ, Anderson JN. Effects of DNA methylation on nucleosome stability. Nucleic Acids Res. 2013;41:2918\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3624_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50850-8","volume":"15","author":"M No\u00eb","year":"2024","unstructured":"No\u00eb M, Mathios D, Annapragada AV, Koul S, Foda ZH, Medina JE, et al. DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentation. Nat Commun. 2024;15:6690.","journal-title":"Nat Commun"},{"key":"3624_CR17","doi-asserted-by":"publisher","first-page":"e0184692","DOI":"10.1371\/journal.pone.0184692","volume":"12","author":"L-H Huang","year":"2017","unstructured":"Huang L-H, Lin P-H, Tsai K-W, Wang L-J, Huang Y-H, Kuo H-C, et al. The effects of storage temperature and duration of blood samples on DNA and RNA qualities. PLoS One. 2017;12:e0184692.","journal-title":"PLoS One"},{"key":"3624_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2025.2453273","volume":"20","author":"I Neefs","year":"2025","unstructured":"Neefs I, Ibrahim J, Peeters M, Van Camp G, Op De Beeck K. The technology landscape for detection of DNA methylation in cancer liquid biopsies. Epigenetics. 2025;20:2453273.","journal-title":"Epigenetics"},{"key":"3624_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2025.2539995","volume":"20","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wen X, Wang L. Advancements in DNA methylation technologies and their application in cancer diagnosis. Epigenetics. 2025;20:2539995.","journal-title":"Epigenetics"},{"key":"3624_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06495-2","volume":"23","author":"M Hum","year":"2025","unstructured":"Hum M, Lee ASG. DNA methylation in breast cancer: early detection and biomarker discovery through current and emerging approaches. J Transl Med. 2025;23:465.","journal-title":"J Transl Med"},{"key":"3624_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13046-025-03322-w","volume":"44","author":"S Sheriff","year":"2025","unstructured":"Sheriff S, Saba M, Patel R, Fisher G, Schroeder T, Arnolda G, et al. A scoping review of factors influencing the implementation of liquid biopsy for cancer care. J Exp Clin Cancer Res. 2025;44:50.","journal-title":"J Exp Clin Cancer Res"},{"key":"3624_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.molmed.2020.12.011","volume":"27","author":"H Luo","year":"2021","unstructured":"Luo H, Wei W, Ye Z, Zheng J, Xu R-H. Liquid biopsy of methylation biomarkers in cell-Free DNA. Trends Mol Med. 2021;27:482\u2013500.","journal-title":"Trends Mol Med"},{"key":"3624_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20:71\u201388.","journal-title":"Nat Rev Genet"},{"key":"3624_CR24","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2147\/CMAR.S235777","volume":"12","author":"MJ Lee","year":"2020","unstructured":"Lee MJ, Hueniken K, Kuehne N, Lu L, Jiang SX, Id Said B, et al. Cancer patient-reported preferences and knowledge for liquid biopsies and blood biomarkers at a comprehensive cancer center. Cancer Manag Res. 2020;12:1163\u201373.","journal-title":"Cancer Manag Res"},{"key":"3624_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154941","volume":"132","author":"DK Dang","year":"2022","unstructured":"Dang DK, Park BH. Circulating tumor DNA: current challenges for clinical utility. J Clin Investig. 2022;132:e154941.","journal-title":"J Clin Investig"},{"key":"3624_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1515\/cclm-2019-0896","volume":"58","author":"J-S Lee","year":"2020","unstructured":"Lee J-S, Kim M, Seong M-W, Kim H-S, Lee YK, Kang HJ. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction. Clin Chem Lab Med. 2020;58:527\u201332.","journal-title":"Clin Chem Lab Med"},{"key":"3624_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103109","volume":"155","author":"LS Pessoa","year":"2020","unstructured":"Pessoa LS, Heringer M, Ferrer VP. ctDNA as a cancer biomarker: a broad overview. Crit Rev Oncol Hematol. 2020;155:103109.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3624_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.canlet.2005.11.027","volume":"243","author":"ZH Huang","year":"2006","unstructured":"Huang ZH, Li LH, Hua D. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett. 2006;243:64\u201370.","journal-title":"Cancer Lett"},{"key":"3624_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fmed.2018.00009","volume":"5","author":"IB Hench","year":"2018","unstructured":"Hench IB, Hench J, Tolnay M. Liquid biopsy in clinical management of breast, lung, and colorectal cancer. Front Med. 2018;5:9.","journal-title":"Front Med"},{"key":"3624_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jmoldx.2025.05.007","volume":"27","author":"WA LaFramboise","year":"2025","unstructured":"LaFramboise WA, Petrosko P, Gallo PH, Gil L, Lam TL, Barr RM, et al. Cell-free DNA, tumor molecular concordance, and clinical correlates of patients with cancer treated in a large community health care network. J Mol Diagn. 2025;27:882\u201398.","journal-title":"J Mol Diagn"},{"key":"3624_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14737159.2020.1860021","volume":"21","author":"OE Bryzgunova","year":"2021","unstructured":"Bryzgunova OE, Konoshenko MY, Laktionov PP. Concentration of cell-free DNA in different tumor types. Expert Rev Mol Diagn. 2021;21:63\u201375.","journal-title":"Expert Rev Mol Diagn"},{"key":"3624_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943253","volume":"12","author":"E S\u00e1nchez-Herrero","year":"2022","unstructured":"S\u00e1nchez-Herrero E, Serna-Blasco R, Robado de Lope L, Gonz\u00e1lez-Rumayor V, Romero A, Provencio M. Circulating tumor DNA as a cancer biomarker: an overview of biological features and factors that may impact on ctDNA analysis. Front Oncol. 2022;12:943253.","journal-title":"Front Oncol"},{"key":"3624_CR33","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/ERC-15-0369","volume":"23","author":"K Warton","year":"2016","unstructured":"Warton K, Mahon KL, Samimi G. Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocr Relat Cancer. 2016;23:R157\u2013171.","journal-title":"Endocr Relat Cancer"},{"key":"3624_CR34","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1515\/cclm-2023-1327","volume":"62","author":"B Wang","year":"2024","unstructured":"Wang B, Wang M, Lin Y, Zhao J, Gu H, Li X. Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management. Clin Chem Lab Med. 2024;62:2111\u201327.","journal-title":"Clin Chem Lab Med"},{"key":"3624_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3726595","volume":"2017","author":"C Leygo","year":"2017","unstructured":"Leygo C, Williams M, Jin HC, Chan MWY, Chu WK, Grusch M, et al. DNA methylation as a noninvasive epigenetic biomarker for the detection of cancer. Disease Markers. 2017;2017:1\u201313.","journal-title":"Disease Markers"},{"key":"3624_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ebiom.2019.05.004","volume":"44","author":"PH Avogbe","year":"2019","unstructured":"Avogbe PH, Manel A, Vian E, Durand G, Forey N, Voegele C, et al. Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer. eBioMedicine. 2019;44:431\u20138.","journal-title":"eBioMedicine"},{"key":"3624_CR37","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/ijms20112657","volume":"20","author":"LK Larsen","year":"2019","unstructured":"Larsen LK, Lind GE, Guldberg P, Dahl C. DNA-methylation-based detection of urological cancer in urine: overview of biomarkers and considerations on biomarker design, source of DNA, and detection technologies. IJMS. 2019;20:2657.","journal-title":"IJMS"},{"key":"3624_CR38","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.humpath.2009.01.004","volume":"40","author":"K Fujita","year":"2009","unstructured":"Fujita K, Pavlovich CP, Netto GJ, Konishi Y, Isaacs WB, Ali S, et al. Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. Hum Pathol. 2009;40:924\u201333.","journal-title":"Hum Pathol"},{"key":"3624_CR39","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1158\/1078-0432.CCR-17-3837","volume":"24","author":"OA Zill","year":"2018","unstructured":"Zill OA, Banks KC, Fairclough SR, Mortimer SA, Vowles JV, Mokhtari R, et al. The Landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients. Clin Cancer Res. 2018;24:3528\u201338.","journal-title":"Clin Cancer Res"},{"key":"3624_CR40","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/pros.20967","volume":"69","author":"SR Payne","year":"2009","unstructured":"Payne SR, Serth J, Schostak M, Kamradt J, Strauss A, Thelen P, et al. DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection. Prostate. 2009;69:1257\u201369.","journal-title":"Prostate"},{"key":"3624_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/hep.32125","volume":"75","author":"HM Vedeld","year":"2022","unstructured":"Vedeld HM, Grimsrud MM, Andresen K, Pharo HD, von Seth E, Karlsen TH, et al. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile. Hepatology. 2022;75:59\u201373.","journal-title":"Hepatology"},{"key":"3624_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100275","volume":"6","author":"Q Gou","year":"2021","unstructured":"Gou Q, Zhang CZ, Sun ZH, Wu LG, Chen Y, Mo ZQ, et al. Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer. ESMO Open. 2021;6:100275.","journal-title":"ESMO Open"},{"key":"3624_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fgene.2020.00324","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhao G, Miao J, Li H, Ma Y, Liu X, et al. Performance comparison between plasma and stool methylated SEPT9 tests for detecting colorectal cancer. Front Genet. 2020;11:324.","journal-title":"Front Genet"},{"key":"3624_CR44","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/neuonc\/noac264","volume":"25","author":"JA Zuccato","year":"2023","unstructured":"Zuccato JA, Patil V, Mansouri S, Voisin M, Chakravarthy A, Shen SY, et al. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. Neuro Oncol. 2023;25:1452\u201360.","journal-title":"Neuro Oncol"},{"key":"3624_CR45","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016;375:1161\u201370.","journal-title":"N Engl J Med"},{"key":"3624_CR46","doi-asserted-by":"crossref","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.","DOI":"10.1136\/bmj.h5527"},{"key":"3624_CR47","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.7150\/thno.35573","volume":"9","author":"RA Hlady","year":"2019","unstructured":"Hlady RA, Zhao X, Pan X, Yang JD, Ahmed F, Antwi SO, et al. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA. Theranostics. 2019;9:7239\u201350.","journal-title":"Theranostics"},{"key":"3624_CR48","doi-asserted-by":"crossref","unstructured":"Liu MC, Klein E, Hubbell E, Maddala T, Aravanis AM, Beausan JF, et al. Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: the circulating cell-free genome atlas (CCGA) study. Ann Oncol. 2018;29:viii14\u2013viii57.","DOI":"10.1093\/annonc\/mdy269.048"},{"key":"3624_CR49","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, Liu MC, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Annals Oncol. 2020;31:745\u201359.","journal-title":"Annals Oncol"},{"key":"3624_CR50","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Annals Oncol. 2021;32:1167\u201377.","journal-title":"Annals Oncol"},{"key":"3624_CR51","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.3390\/diagnostics13243670","volume":"13","author":"I Nel","year":"2023","unstructured":"Nel I, M\u00fcnch C, Shamkeeva S, Heinemann ML, Isermann B, Aktas B. The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine. Diagnostics. 2023;13:3670.","journal-title":"Diagnostics"},{"key":"3624_CR52","doi-asserted-by":"crossref","unstructured":"Andersson E, Dahmcke CM, Steven K, Larsen LK, Guldberg P. Filtration device for on-site collection, storage and shipment of cells from urine and its application to DNA-based detection of bladder cancer. PLoS ONE. 2015;10:e0131889.","DOI":"10.1371\/journal.pone.0131889"},{"key":"3624_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1373\/clinchem.2019.306837","volume":"66","author":"R Lampignano","year":"2020","unstructured":"Lampignano R, Neumann MHD, Weber S, Kloten V, Herdean A, Voss T, et al. Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (Pre)analytical work flows. Clin Chem. 2020;66:149\u201360.","journal-title":"Clin Chem"},{"key":"3624_CR54","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cpt.666","volume":"101","author":"RL Grossman","year":"2017","unstructured":"Grossman RL, Abel B, Angiuoli S, Barrett JC, Bassett D, Bramlett K, et al. Collaborating to compete: blood profiling atlas in cancer (BloodPAC) consortium. Clin Pharm Ther. 2017;101:589\u201392.","journal-title":"Clin Pharm Ther"},{"key":"3624_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cpt.3416","volume":"117","author":"CM Lockwood","year":"2025","unstructured":"Lockwood CM, Merker JD, Bain E, Compton C, Grossman RL, Johann D, et al. Towards preanalytical best practices for liquid biopsy studies: a BLOODPAC landscape analysis. Clin Pharm Ther. 2025;117:28\u201333.","journal-title":"Clin Pharm Ther"},{"key":"3624_CR56","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/15592294.2017.1334024","volume":"12","author":"M-B Worm \u00d8rntoft","year":"2017","unstructured":"Worm \u00d8rntoft M-B, Jensen S\u00d8, Hansen TB, Bramsen JB, Andersen CL. Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA. Epigenetics. 2017;12:626\u201336.","journal-title":"Epigenetics"},{"key":"3624_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13148-023-01563-0","volume":"15","author":"SH Kresse","year":"2023","unstructured":"Kresse SH, Brandt-Winge S, Pharo H, Flatin BTB, Jeanmougin M, Vedeld HM, et al. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood. Clin Epigenet. 2023;15:151.","journal-title":"Clin Epigenet"},{"key":"3624_CR58","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1101\/gr.266551.120","volume":"31","author":"R Vaisvila","year":"2021","unstructured":"Vaisvila R, Ponnaluri VKC, Sun Z, Langhorst BW, Saleh L, Guan S, et al. Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Res. 2021;31:1280\u20139.","journal-title":"Genome Res"},{"key":"3624_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-025-01901-4","volume":"17","author":"SH Kresse","year":"2025","unstructured":"Kresse SH, Thorkildsen EM, Brandt-Winge S, Pharo H, Vedeld HM, Lind GE. Comparison of enzymatic and bisulfite conversion of circulating cell-free tumor DNA for DNA methylation analyses. Clin Epigenet. 2025;17:93.","journal-title":"Clin Epigenet"},{"key":"3624_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10275-2","volume":"22","author":"TJ Oh","year":"2022","unstructured":"Oh TJ, Lim E, Bang B-R, Lee JJ, Na YG, Shin JH, et al. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA. BMC Cancer. 2022;22:1195.","journal-title":"BMC Cancer"},{"key":"3624_CR61","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1245\/s10434-014-4277-2","volume":"22","author":"P-C Lin","year":"2015","unstructured":"Lin P-C, Lin J-K, Lin C-H, Lin H-H, Yang S-H, Jiang J-K, et al. Clinical relevance of plasma DNA methylation in colorectal cancer patients identified by using a genome-wide high-resolution array. Ann Surg Oncol. 2015;22:1419\u201327.","journal-title":"Ann Surg Oncol"},{"key":"3624_CR62","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nmat4997","volume":"16","author":"R Xu","year":"2017","unstructured":"Xu R, Wei W, Krawczyk M, Wang W, Luo H, Flagg K, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nature Mater. 2017;16:1155\u201361.","journal-title":"Nature Mater"},{"key":"3624_CR63","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/annonc\/mdy119","volume":"29","author":"L Liu","year":"2018","unstructured":"Liu L, Toung JM, Jassowicz AF, Vijayaraghavan R, Kang H, Zhang R, et al. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. Ann Oncol. 2018;29:1445\u201353.","journal-title":"Ann Oncol"},{"key":"3624_CR64","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41551-021-00746-5","volume":"5","author":"N Liang","year":"2021","unstructured":"Liang N, Li B, Jia Z, Wang C, Wu P, Zheng T, et al. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat Biomed Eng. 2021;5:586\u201399.","journal-title":"Nat Biomed Eng"},{"key":"3624_CR65","doi-asserted-by":"crossref","unstructured":"Lange CPE, Campan M, Hinoue T, Schmitz RF, Van Der Meulen-de Jong AE, Slingerland H, et al. Genome-scale discovery of dna-methylation biomarkers for blood-based detection of colorectal cancer. Marsit CJ, editor. PLoS ONE. 2012;7:e50266.","DOI":"10.1371\/journal.pone.0050266"},{"key":"3624_CR66","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/oncolo\/oyac204","volume":"28","author":"MA Gouda","year":"2023","unstructured":"Gouda MA, Duose DY, Lapin M, Zalles S, Huang HJ, Xi Y, et al. Mutation-agnostic detection of colorectal cancer using liquid biopsy-based methylation-specific signatures. Oncologist. 2023;28:368\u201372.","journal-title":"Oncologist"},{"key":"3624_CR67","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/neuonc\/noab023","volume":"23","author":"TS Sabedot","year":"2021","unstructured":"Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, deCarvalho AC, et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncol. 2021;23:1494\u2013508.","journal-title":"Neuro-Oncol"},{"key":"3624_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13148-023-01570-1","volume":"15","author":"M Gallardo-G\u00f3mez","year":"2023","unstructured":"Gallardo-G\u00f3mez M, Rodr\u00edguez-Girondo M, Planell N, Moran S, Bujanda L, Etxart A, et al. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas. Clin Epigenet. 2023;15:157.","journal-title":"Clin Epigenet"},{"key":"3624_CR69","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/15592294.2021.1924970","volume":"17","author":"D Beck","year":"2022","unstructured":"Beck D, Ben Maamar M, Skinner MK. Genome-wide CpG density and DNA methylation analysis method (MeDIP, RRBS, and WGBS) comparisons. Epigenetics. 2022;17:518\u201330.","journal-title":"Epigenetics"},{"key":"3624_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13148-022-01335-2","volume":"14","author":"HD Pharo","year":"2022","unstructured":"Pharo HD, Jeanmougin M, Ager-Wick E, Vedeld HM, S\u00f8rb\u00f8 AK, Dahl C, et al. BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients. Clin Epigenet. 2022;14:115.","journal-title":"Clin Epigenet"},{"key":"3624_CR71","doi-asserted-by":"publisher","first-page":"18761","DOI":"10.1073\/pnas.1313995110","volume":"110","author":"KCA Chan","year":"2013","unstructured":"Chan KCA, Jiang P, Chan CWM, Sun K, Wong J, Hui EP, et al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci USA. 2013;110:18761\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3624_CR72","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature. 2018;563:579\u201383.","journal-title":"Nature"},{"key":"3624_CR73","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1093\/nar\/gki901","volume":"33","author":"A Meissner","year":"2005","unstructured":"Meissner A. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 2005;33:5868\u201377.","journal-title":"Nucleic Acids Res"},{"key":"3624_CR74","unstructured":"De Koker A, Raman L, Van Paemel R, Van der Linden M, Van de Velde S, van der Leest P, et al. Development of circulating cell-free DNA reduced representation bisulfite sequencing for clinical methylomics diagnostics. bioRxiv. 2025;663195."},{"key":"3624_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02178-6","volume":"23","author":"H-Q Si","year":"2024","unstructured":"Si H-Q, Wang P, Long F, Zhong W, Meng Y-D, Rong Y, et al. Cancer liquid biopsies by Oxford Nanopore Technologies sequencing of cell-free DNA: from basic research to clinical applications. Mol Cancer. 2024;23:265.","journal-title":"Mol Cancer"},{"key":"3624_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01178-3","volume":"15","author":"BT Lau","year":"2023","unstructured":"Lau BT, Almeda A, Schauer M, McNamara M, Bai X, Meng Q, et al. Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing. Genome Med. 2023;15:33.","journal-title":"Genome Med"},{"key":"3624_CR77","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1158\/1078-0432.CCR-17-1222","volume":"23","author":"A Ooki","year":"2017","unstructured":"Ooki A, Maleki Z, Tsay J-CJ, Goparaju C, Brait M, Turaga N, et al. A panel of novel detection and prognostic methylated DNA markers in primary non\u2013small cell lung cancer and serum DNA. Clin Cancer Res. 2017;23:7141\u201352.","journal-title":"Clin Cancer Res"},{"key":"3624_CR78","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1158\/1078-0432.CCR-21-1982","volume":"27","author":"R Kandimalla","year":"2021","unstructured":"Kandimalla R, Xu J, Link A, Matsuyama T, Yamamura K, Parker MI, et al. EpiPanGI Dx: a cell-free DNA methylation fingerprint for the early detection of gastrointestinal cancers. Clin Cancer Res. 2021;27:6135\u201344.","journal-title":"Clin Cancer Res"},{"key":"3624_CR79","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41591-020-0933-1","volume":"26","author":"PV Nuzzo","year":"2020","unstructured":"Nuzzo PV, Berchuck JE, Korthauer K, Spisak S, Nassar AH, Abou Alaiwi S, et al. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. Nat Med. 2020;26:1041\u20133.","journal-title":"Nat Med"},{"key":"3624_CR80","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/nar\/gky423","volume":"46","author":"W Li","year":"2018","unstructured":"Li W, Li Q, Kang S, Same M, Zhou Y, Sun C, et al. CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data. Nucleic Acids Res. 2018;46:e89\u2013e89.","journal-title":"Nucleic Acids Res"},{"key":"3624_CR81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41698-021-00198-9","volume":"5","author":"K Cristall","year":"2021","unstructured":"Cristall K, Bidard F-C, Pierga J-Y, Rauh MJ, Popova T, Sebbag C, et al. A DNA methylation-based liquid biopsy for triple-negative breast cancer. npj Precis Onc. 2021;5:53.","journal-title":"npj Precis Onc"},{"key":"3624_CR82","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/hep4.1730","volume":"5","author":"JD Yang","year":"2021","unstructured":"Yang JD, Ghoz H, Aboelsoud MM, Taylor WR, Yab TC, Berger CK, et al. DNA methylation markers for detection of cholangiocarcinoma: discovery, validation, and clinical testing in biliary brushings and plasma. Hepatol Commun. 2021;5:1448\u201359.","journal-title":"Hepatol Commun"},{"key":"3624_CR83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2217\/epi-2023-0248","volume":"16","author":"TC Stone","year":"2024","unstructured":"Stone TC, Ward V, Hogan A, Alexander Ho KM, Wilson A, McBain H, et al. Using saliva epigenetic data to develop and validate a multivariable predictor of esophageal cancer status. Epigenomics. 2024;16:109\u201325.","journal-title":"Epigenomics"},{"key":"3624_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:3156.","journal-title":"Genome Biol"},{"key":"3624_CR85","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.juro.2012.05.003","volume":"188","author":"P O\u2019Sullivan","year":"2012","unstructured":"O\u2019Sullivan P, Sharples K, Dalphin M, Davidson P, Gilling P, Cambridge L, et al. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria. J Urol. 2012;188:741\u20137.","journal-title":"J Urol"},{"key":"3624_CR86","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7326\/M15-0997","volume":"163","author":"R Chou","year":"2015","unstructured":"Chou R, Gore JL, Buckley D, Fu R, Gustafson K, Griffin JC, et al. Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis. Ann Intern Med. 2015;163:922\u201331.","journal-title":"Ann Intern Med"},{"key":"3624_CR87","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/1078-0432.CCR-07-1672","volume":"14","author":"A Holyoake","year":"2008","unstructured":"Holyoake A, O\u2019Sullivan P, Pollock R, Best T, Watanabe J, Kajita Y, et al. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Clin Cancer Res. 2008;14:742\u20139.","journal-title":"Clin Cancer Res"},{"key":"3624_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/15592294.2017.1412907","volume":"13","author":"L Vrba","year":"2018","unstructured":"Vrba L, Futscher BW. A suite of DNA methylation markers that can detect most common human cancers. Epigenetics. 2018;13:61\u201372.","journal-title":"Epigenetics"},{"key":"3624_CR89","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/15592294.2019.1695333","volume":"15","author":"L Vrba","year":"2020","unstructured":"Vrba L, Oshiro MM, Kim SS, Garland LL, Placencia C, Mahadevan D, et al. DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients. Epigenetics. 2020;15:419\u201330.","journal-title":"Epigenetics"},{"key":"3624_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53754-1","volume":"14","author":"T Dra\u0161kovi\u010d","year":"2024","unstructured":"Dra\u0161kovi\u010d T, Hauptman N. Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases. Sci Rep. 2024;14:3095.","journal-title":"Sci Rep"},{"key":"3624_CR91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13148-016-0303-5","volume":"9","author":"A Feber","year":"2017","unstructured":"Feber A, Dhami P, Dong L, De Winter P, Tan WS, Mart\u00ednez-Fern\u00e1ndez M, et al. UroMark\u2014a urinary biomarker assay for the detection of bladder cancer. Clin Epigenet. 2017;9:8.","journal-title":"Clin Epigenet"},{"key":"3624_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-54","volume":"14","author":"SM Mitchell","year":"2014","unstructured":"Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, et al. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer. 2014;14:54.","journal-title":"BMC Cancer"},{"key":"3624_CR93","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nbt.3605","volume":"34","author":"BLUEPRINT consortium.","year":"2016","unstructured":"BLUEPRINT consortium. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nat Biotechnol. 2016;34:726\u201337.","journal-title":"Nat Biotechnol"},{"key":"3624_CR94","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14:531\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"3624_CR95","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011;83:8604\u201310.","journal-title":"Anal Chem"},{"key":"3624_CR96","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1158\/1078-0432.CCR-22-0444","volume":"28","author":"SM Batool","year":"2022","unstructured":"Batool SM, Muralidharan K, Hsia T, Falotico S, Gamblin AS, Rosenfeld YB, et al. Highly sensitive EGFRvIII detection in circulating extracellular vesicle RNA of glioma patients. Clin Cancer Res. 2022;28:4070\u201382.","journal-title":"Clin Cancer Res"},{"key":"3624_CR97","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13046-024-03166-w","volume":"43","author":"K-L Reese","year":"2024","unstructured":"Reese K-L, Pantel K, Smit DJ. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer\u2014a comprehensive review. J Exp Clin Cancer Res. 2024;43:250.","journal-title":"J Exp Clin Cancer Res"},{"key":"3624_CR98","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/epi-2017-0053","volume":"9","author":"GE Lind","year":"2017","unstructured":"Lind GE, Van Engeland M. Details matter: the role of genomic location and assay standardization in DNA methylation analyses. Epigenomics. 2017;9:933\u20135.","journal-title":"Epigenomics"},{"key":"3624_CR99","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1053\/j.gastro.2006.06.006","volume":"131","author":"Y Mori","year":"2006","unstructured":"Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, et al. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology. 2006;131:797\u2013808.","journal-title":"Gastroenterology"},{"key":"3624_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-6-13","volume":"6","author":"GE Lind","year":"2008","unstructured":"Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, Alonso MA, et al. Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. J Transl Med. 2008;6:13.","journal-title":"J Transl Med"},{"key":"3624_CR101","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1053\/j.gastro.2007.03.003","volume":"132","author":"GE Lind","year":"2007","unstructured":"Lind GE, Ahlquist T, Lothe RA. DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors. Gastroenterology. 2007;132:1631\u20132.","journal-title":"Gastroenterology"},{"key":"3624_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/srep33936","volume":"6","author":"HD Pharo","year":"2016","unstructured":"Pharo HD, Honne H, Vedeld HM, Dahl C, Andresen K, Liest\u00f8l K, et al. Experimental factors affecting the robustness of DNA methylation analysis. Sci Rep. 2016;6:33936.","journal-title":"Sci Rep"},{"key":"3624_CR103","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1093\/nar\/gkn455","volume":"36","author":"DJ Weisenberger","year":"2008","unstructured":"Weisenberger DJ, Trinh BN, Campan M, Sharma S, Long TI, Ananthnarayan S, et al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res. 2008;36:4689\u201398.","journal-title":"Nucleic Acids Res"},{"key":"3624_CR104","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-018-0456-5","volume":"10","author":"HD Pharo","year":"2018","unstructured":"Pharo HD, Andresen K, Berg KCG, Lothe RA, Jeanmougin M, Lind GE. A robust internal control for high-precision DNA methylation analyses by droplet digital PCR. Clin Epigenet. 2018;10:24.","journal-title":"Clin Epigenet"},{"key":"3624_CR105","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/clinchem\/hvad063","volume":"69","author":"M Vynck","year":"2023","unstructured":"Vynck M, Chen Y, Gleerup D, Vandesompele J, Trypsteen W, Lievens A, et al. Digital PCR partition classification. Clin Chem. 2023;69:976\u201390.","journal-title":"Clin Chem"},{"key":"3624_CR106","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac766","volume":"39","author":"M Jeanmougin","year":"2023","unstructured":"Jeanmougin M, Brodal HP, Dietrichson Pharo H, Vedeld HM, Lind GE. PoDCall: positive droplet calling and normalization of droplet digital PCR DNA methylation data. Bioinformatics. 2023;39:btac766.","journal-title":"Bioinformatics"},{"key":"3624_CR107","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611\u201322.","journal-title":"Clin Chem"},{"key":"3624_CR108","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","volume":"59","author":"JF Huggett","year":"2013","unstructured":"Huggett JF, Foy CA, Benes V, Emslie K, Garson JA, Haynes R, et al. The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments. Clin Chem. 2013;59:892\u2013902.","journal-title":"Clin Chem"},{"key":"3624_CR109","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/clinchem\/hvaa125","volume":"66","author":"AS Whale","year":"2020","unstructured":"The dMIQE Group, Whale AS, De Spiegelaere W, Trypsteen W, Nour AA, Bae Y-K, et al. The digital MIQE guidelines update: minimum information for publication of quantitative digital PCR experiments for 2020. Clin Chem. 2020;66:1012\u201329.","journal-title":"Clin Chem"},{"key":"3624_CR110","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s43856-024-00671-z","volume":"4","author":"M Smelik","year":"2024","unstructured":"Smelik M, Zhao Y, Mansour Aly D, Mahmud AF, Sysoev O, Li X, et al. Multiomics biomarkers were not superior to clinical variables for pan-cancer screening. Commun Med. 2024;4:234.","journal-title":"Commun Med"},{"key":"3624_CR111","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/clinchem\/hvac122","volume":"68","author":"B Salfer","year":"2022","unstructured":"Salfer B, Li F, Wong DTW, Zhang L. Urinary cell-free DNA in liquid biopsy and cancer management. Clin Chem. 2022;68:1493\u2013501.","journal-title":"Clin Chem"},{"key":"3624_CR112","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1200\/JCO.20.01572","volume":"39","author":"DF Hayes","year":"2021","unstructured":"Hayes DF. Defining clinical utility of tumor biomarker tests: a clinician\u2019s viewpoint. JCO. 2021;39:238\u201348.","journal-title":"JCO"},{"key":"3624_CR113","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","volume":"187","author":"A Passaro","year":"2024","unstructured":"Passaro A, Al Bakir M, Hamilton EG, Diehn M, Andr\u00e9 F, Roy-Chowdhuri S, et al. Cancer biomarkers: emerging trends and clinical implications for personalized treatment. Cell. 2024;187:1617\u201335.","journal-title":"Cell"},{"key":"3624_CR114","doi-asserted-by":"publisher","first-page":"743","DOI":"10.5858\/133.5.743","volume":"133","author":"L Jennings","year":"2009","unstructured":"Jennings L, Van Deerlin VM, Gulley ML. College of American Pathologists Molecular Pathology Resource Committee. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med. 2009;133:743\u201355.","journal-title":"Arch Pathol Lab Med"},{"key":"3624_CR115","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/17520363.1.3.419","volume":"1","author":"NI Parikh","year":"2007","unstructured":"Parikh NI, Vasan RS. Assessing the clinical utility of biomarkers in medicine. Biomark Med. 2007;1:419\u201336.","journal-title":"Biomark Med"},{"key":"3624_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636561","volume":"11","author":"A Krendyukov","year":"2021","unstructured":"Krendyukov A, Singhvi S, Zabransky M. Value of adaptive trials and surrogate endpoints for clinical decision-making in rare cancers. Front Oncol. 2021;11:636561.","journal-title":"Front Oncol"},{"key":"3624_CR117","doi-asserted-by":"publisher","first-page":"53","DOI":"10.29245\/2572-9411\/2016\/3.1054","volume":"1","author":"R Hilgers","year":"2016","unstructured":"Hilgers R. Design and analysis of clinical trials for small rare disease populations. J Rare Dis Res Treat. 2016;1:53\u201360.","journal-title":"J Rare Dis Res Treat"},{"key":"3624_CR118","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/jnci\/djp335","volume":"101","author":"RM Simon","year":"2009","unstructured":"Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. JNCI J Natl Cancer Inst. 2009;101:1446\u201352.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"3624_CR119","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1373\/clinchem.2007.095992","volume":"54","author":"C Lofton-Day","year":"2008","unstructured":"Lofton-Day C, Model F, DeVos T, Tetzner R, Distler J, Schuster M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54:414\u201323.","journal-title":"Clin Chem"},{"key":"3624_CR120","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1373\/clinchem.2008.115808","volume":"55","author":"T deVos","year":"2009","unstructured":"deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55:1337\u201346.","journal-title":"Clin Chem"},{"key":"3624_CR121","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1373\/clinchem.2013.221044","volume":"60","author":"NT Potter","year":"2014","unstructured":"Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, et al. Validation of a real-time PCR\u2013based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 2014;60:1183\u201391.","journal-title":"Clin Chem"},{"key":"3624_CR122","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s40291-020-00473-8","volume":"24","author":"M Shirley","year":"2020","unstructured":"Shirley M. Epi proColon\u00ae for colorectal cancer screening: a profile of its use in the USA. Mol Diagn Ther. 2020;24:497\u2013503.","journal-title":"Mol Diagn Ther"},{"key":"3624_CR123","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa2304714","volume":"390","author":"DC Chung","year":"2024","unstructured":"Chung DC, Gray DM, Singh H, Issaka RB, Raymond VM, Eagle C, et al. A cell-free DNA blood-based test for colorectal cancer screening. N Engl J Med. 2024;390:973\u201383.","journal-title":"N Engl J Med"},{"key":"3624_CR124","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","volume":"370","author":"TF Imperiale","year":"2014","unstructured":"Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287\u201397.","journal-title":"N Engl J Med"},{"key":"3624_CR125","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1056\/NEJMoa2310336","volume":"390","author":"TF Imperiale","year":"2024","unstructured":"Imperiale TF, Porter K, Zella J, Gagrat ZD, Olson MC, Statz S, et al. Next-generation multitarget stool DNA test for colorectal cancer screening. N Engl J Med. 2024;390:984\u201393.","journal-title":"N Engl J Med"},{"key":"3624_CR126","doi-asserted-by":"publisher","first-page":"12489","DOI":"10.3390\/ijms241512489","volume":"24","author":"V Fiorentino","year":"2023","unstructured":"Fiorentino V, Pizzimenti C, Franchina M, Rossi ED, Tralongo P, Carlino A, et al. Bladder Epicheck test: a novel tool to support urothelial carcinoma diagnosis in urine samples. IJMS. 2023;24:12489.","journal-title":"IJMS"},{"key":"3624_CR127","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","volume":"1","author":"JA Witjes","year":"2018","unstructured":"Witjes JA, Morote J, Cornel EB, Gakis G, van Valenberg FJP, Lozano F, et al. Performance of the bladder EpiCheckTM methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial. Eur Urol Oncol. 2018;1:307\u201313.","journal-title":"Eur Urol Oncol"},{"key":"3624_CR128","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.humpath.2021.09.007","volume":"118","author":"F Pierconti","year":"2021","unstructured":"Pierconti F, Martini M, Fiorentino V, Cenci T, Racioppi M, Foschi N, et al. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. Hum Pathol. 2021;118:42\u20138.","journal-title":"Hum Pathol"},{"key":"3624_CR129","doi-asserted-by":"crossref","unstructured":"Pedersen SK, Baker RT, McEvoy A, Murray DH, Thomas M, Molloy PL, et al. A two-gene blood test for methylated DNA sensitive for colorectal cancer. PLoS ONE. 2015;10:e0125041.","DOI":"10.1371\/journal.pone.0125041"},{"key":"3624_CR130","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1373\/jalm.2017.023135","volume":"2","author":"DH Murray","year":"2017","unstructured":"Murray DH, Baker RT, Gaur S, Young GP, Pedersen SK. Validation of a circulating tumor-derived DNA blood test for detection of methylated BCAT1 and IKZF1 DNA. J Appl Lab Med. 2017;2:165\u201375.","journal-title":"J Appl Lab Med"},{"key":"3624_CR131","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/hep4.1918","volume":"6","author":"N Lin","year":"2022","unstructured":"Lin N, Lin Y, Xu J, Liu D, Li D, Meng H, et al. A multi-analyte cell-free DNA\u2013based blood test for early detection of hepatocellular carcinoma. Hepatol Commun. 2022;6:1753\u201363.","journal-title":"Hepatol Commun"},{"key":"3624_CR132","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1053\/j.gastro.2021.08.054","volume":"161","author":"G Cai","year":"2021","unstructured":"Cai G, Cai M, Feng Z, Liu R, Liang L, Zhou P, et al. A multilocus blood-based assay targeting circulating tumor DNA methylation enables early detection and early relapse prediction of colorectal cancer. Gastroenterology. 2021;161:2053\u20132056.e2.","journal-title":"Gastroenterology"},{"key":"3624_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17316-z","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Gole J, Gore A, He Q, Lu M, Min J, et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat Commun. 2020;11:3475.","journal-title":"Nat Commun"},{"key":"3624_CR134","doi-asserted-by":"crossref","unstructured":"Piatti P, Chew YC, Suwoto M, Yamada T, Jara B, Jia X-Y, et al. Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples. Clin Epigenet. 2021. Available from: https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-021-01029-1","DOI":"10.1186\/s13148-021-01029-1"},{"key":"3624_CR135","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jmoldx.2024.04.001","volume":"26","author":"B-R Bang","year":"2024","unstructured":"Bang B-R, Zhong J, Oh TJ, Lee JY, Seo Y, Woo MA, et al. EarlyTect BCD, a streamlined PENK methylation test in urine DNA, effectively detects bladder cancer in patients with hematuria. J Mol Diagn. 2024;26:613\u201323.","journal-title":"J Mol Diagn"},{"key":"3624_CR136","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.annonc.2023.02.010","volume":"34","author":"Q Gao","year":"2023","unstructured":"Gao Q, Lin YP, Li BS, Wang GQ, Dong LQ, Shen BY, et al. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies. Ann Oncol. 2023;34:486\u201395.","journal-title":"Ann Oncol"},{"key":"3624_CR137","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.cgh.2020.08.065","volume":"19","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Ramasubramanian TS, Bhattacharya A, Olson MC, Edwards V DK, Roberts LR, et al. A Novel blood-based panel of methylated dna and protein markers for detection of early-stage hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2021;19:2597\u20132605.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3624_CR138","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cgh.2021.08.010","volume":"20","author":"NP Chalasani","year":"2022","unstructured":"Chalasani NP, Porter K, Bhattacharya A, Book AJ, Neis BM, Xiong KM, et al. Validation of a novel multitarget blood test shows high sensitivity to detect early stage hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2022;20:173\u2013182.e7.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3624_CR139","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jtho.2016.08.123","volume":"12","author":"G Weiss","year":"2017","unstructured":"Weiss G, Schlegel A, Kottwitz D, K\u00f6nig T, Tetzner R. Validation of the SHOX2\/PTGER4 DNA methylation marker panel for plasma-based discrimination between patients with malignant and nonmalignant lung disease. J Thorac Oncol. 2017;12:77\u201384.","journal-title":"J Thorac Oncol"},{"key":"3624_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2748-5","volume":"16","author":"J-P Roperch","year":"2016","unstructured":"Roperch J-P, Grandchamp B, Desgrandchamps F, Mongiat-Artus P, Ravery V, Ouzaid I, et al. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive\/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer. BMC Cancer. 2016;16:704.","journal-title":"BMC Cancer"},{"key":"3624_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0788-z","volume":"18","author":"N Uehiro","year":"2016","unstructured":"Uehiro N, Sato F, Pu F, Tanaka S, Kawashima M, Kawaguchi K, et al. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res. 2016;18:129.","journal-title":"Breast Cancer Res"},{"key":"3624_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1191-5","volume":"18","author":"S Kang","year":"2017","unstructured":"Kang S, Li Q, Chen Q, Zhou Y, Park S, Lee G, et al. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 2017;18:53.","journal-title":"Genome Biol"},{"key":"3624_CR143","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13148-019-0757-3","volume":"11","author":"S\u00d8 Jensen","year":"2019","unstructured":"Jensen S\u00d8, \u00d8gaard N, \u00d8rntoft M-BW, Rasmussen MH, Bramsen JB, Kristensen H, et al. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer\u2014a clinical biomarker discovery and validation study. Clin Epigenet. 2019;11:158.","journal-title":"Clin Epigenet"},{"key":"3624_CR144","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ijc.34337","volume":"152","author":"M Manoochehri","year":"2023","unstructured":"Manoochehri M, Borhani N, Gerh\u00e4user C, Assenov Y, Sch\u00f6nung M, Hielscher T, et al. DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy. Intl J Cancer. 2023;152:1025\u201335.","journal-title":"Intl J Cancer"},{"key":"3624_CR145","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/15592294.2020.1790950","volume":"16","author":"R Van Paemel","year":"2021","unstructured":"Van Paemel R, De Koker A, Vandeputte C, Van Zogchel L, Lammens T, Laureys G, et al. Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study. Epigenetics. 2021;16:196\u2013208.","journal-title":"Epigenetics"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03624-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T23:03:00Z","timestamp":1764198180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03624-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":145,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025,12,18]]}},"alternative-id":["3624"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03624-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GEL has been granted a patent (EP2630261B1\/US09797016B2) for biomarkers related to bladder cancer detection. Additionally, GEL and HP are named inventors on a pending PCT patent application (WO\/2020\/099938) covering biomarkers utilized in the BladMetrix test for bladder cancer detection. GEL and HP are named inventors on a granted patent (US11555222B2) for the 4Plex control, which is mentioned in the present study for standardization of DNA methylation ddPCR results. The 4Plex control has been made freely available to the scientific community. Remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}